Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Hair loss severity is linked to depression, not anxiety, in Filipino men, with older, less educated men with more hair loss at higher risk.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Hair cortisol levels don't reliably indicate chronic stress in people with multiple sclerosis.

AAG causes hair loss in many people, with limited treatments like finasteride, minoxidil, light therapy, and hair transplants.

Androgenetic alopecia requires a personalized treatment plan and psychological support to improve quality of life.

Alopecia areata requires addressing both emotional and financial challenges for better patient care.

Androgenetic Alopecia (AGA) greatly lowers quality of life, causing stress and low self-esteem, with those seeking treatment experiencing more impairment.

AGA patients have a lower quality of life than AA patients.

Androgenetic alopecia (AGA) is a common, hereditary hair loss condition that can be slowed but not permanently reversed with available therapies.

Hair loss affects self-esteem; patients seek effective, low side-effect treatments.

Hair loss affects quality of life, self-esteem, and confidence, but younger patients cope better.

Different hair loss types need accurate diagnosis for proper treatment.

People with hair loss feel more depressed and anxious, especially women, and need help managing emotions and beliefs about their condition.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

The FAW-FS algorithm improves depression recognition, and psychological interventions help AGA patients' mental health.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

Hair loss lowers young men's self-esteem, increasing social anxiety and affecting daily life.

Hair loss lowers quality of life, causing embarrassment, frustration, and sexual rejection.

ALUDWIG can help standardize female hair loss assessment from a single image.

Androgenetic alopecia is common, affects self-image, and has no complete cure yet.

People with androgenetic alopecia often experience more anxiety, depression, and lower self-esteem.

Women with hair loss often feel depressed, while men are more anxious and aggressive.

Hair loss can cause low self-esteem, anxiety, and depression in men.

Patients were generally dissatisfied with over-the-counter hair growth products but wanted to consult doctors for hair loss treatment.